Health In Tech Inc

Análisis de la acción Health In Tech Inc (HIT)

$0.968

+0.008 (+0.83%)Al cierre

Loading chart…
High
0.980
Open
0.970
VWAP
0.96
Vol
37.30K
Mkt Cap
Low
0.939
Amount
35.90K
EV/EBITDA, TTM
-1.95

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.

AI analysis of Health In Tech Inc (HIT)

hold

Health In Tech, Inc. is currently not a good buy due to its declining revenue and negative earnings, despite a potential upside indicated by analyst targets. The current price is $0.98, with a forward P/E of 136.99, suggesting high expectations for future earnings. However, the company has reported a significant year-to-date decline of 44% and a one-year change of -65.97%, indicating ongoing financial struggles. The main risk is the recent revenue decline of 13.5% year-over-year, which raises concerns about its short-term performance.

Métricas de valoración

The current forward P/E ratio for Health In Tech Inc (HIT) is 136.99, compared to its 5-year average forward P/E of 67.90.

Forward P/E

Overvalued
5Y Average P/E
67.90
Current P/E
136.99
Sobrevalorada
123.84
Infravalorada
11.96

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.88
Current EV/EBITDA
-1.95
Sobrevalorada
19.34
Infravalorada
-5.58

Forward P/S

Fair
5Y Average P/S
1.67
Current P/S
0.88
Sobrevalorada
2.99
Infravalorada
0.35

Cronología de eventos

2026-08-13 (ET)

17:00:00

Health In Tech Sees 2026 Revenue of $45M-$50M

17:00:00

Company Reports Q2 Revenue of $8.1MM, Exceeding Expectations

2026-06-11 (ET)

12:30:00

Health In Tech Files $300M Mixed Securities Shelf

2026-05-13 (ET)

16:10:00

Health In Tech Reiterates 2026 Revenue Guidance of $45M to $50M

16:10:00

Health In Tech Reports Q1 Revenue of $8.8M, Beating Expectations

Noticias

HIT FAQ — answered by Alphio AI

Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform. It operates in the Financials sector.

Health In Tech, Inc. is currently not a good buy due to its declining revenue and negative earnings, despite a potential upside indicated by analyst targets. The current price is $0.98, with a forward P/E of 136.99, suggesting high expectations for future earnings. However, the company has reported a significant year-to-date decline of 44% and a one-year change of -65.97%, indicating ongoing financial struggles. The main risk is the recent revenue decline of 13.5% year-over-year, which raises concerns about its short-term performance.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis